Product code PHL— Physical Medicine
Atalante X
- Classification name
- Powered Exoskeleton
- Device class
- Class 2
- Regulation
- 21 CFR 890.3480
- Advisory panel
- Physical Medicine
- Total cleared
- 26
- First cleared
- Most recent
FDA classification definition
“A powered exoskeleton is a prescription device that is composed of an external, powered, motorized orthosis that is placed over a person's paralyzed or weakened lower extremity limb(s) for medical purposes.”
Market context for product code PHL
FDA has cleared devices under product code PHL between 2014 and 2026, filed by 14 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.
Clearances per year
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2014
Top applicants under product code PHL
Recent clearances under product code PHL
- K254198 — Trexo Theo
- K260381 — Eve
- K250904 — Atalante X
- K241822 — ReWalk® 7 Personal Exoskeleton (50-20-0005)
- K233695 — Medical HAL Lower Limb Type (HAL-ML)
- K232077 — Atalante X
- K221696 — ReWalk P6.0
- K221859 — Atalante
- K220988 — EksoNR
- K213452 — GEMS-H
- K201473 — ExoAtlet-II
- K201559 — HAL for Medical Use(Lower Limb type)
- K201539 — Keeogo Dermoskeleton System
- K200574 — EksoNR
- K200032 — ReWalk P6.0
- K190337 — ReWalk Restore
- K183152 — Phoenix
- K181294 — Honda Walking Assist Device
- K173530 — Indego(R)
- K171909 — HAL for Medical Use (Lower Limb Type)
- K171334 — Indego
- K160987 — ReWalk(TM)
- K161443 — Ekso (version 1.1) and Ekso GT (version 1.2)
- K143690 — Ekso (version 1.1) and Ekso GT (version 1.2)
- K152416 — Indego
- DEN130034 — REWALK
Data sourced from openFDA. This site is unofficial and independent of the FDA.